Paragon Biosciences Completes Sale of Emalex Biosciences to Teva, Marking Another Milestone in CNS Drug Innovation Paragon Biosciences has announced the successful completion of the sale of Emalex Biosciences to…
BeOne Medicines Highlights Long-Term BRUKINSA Benefits in Older CLL Patients at EHA 2026 BeOne Medicines Ltd., a global oncology company dedicated to advancing innovative cancer therapies, has announced the presentation…
LivaNova Strengthens Board Leadership with Appointment of Jette Nygaard-Andersen LivaNova PLC, a global medical technology company focused on developing innovative therapies for patients with neurological and cardiovascular conditions, has announced…
Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as…
Anocca Doses First Patients in VIDAR-1 Trial of ANOC-001 TCR-T Therapy for KRAS-Mutated Pancreatic Cancer Anocca AB, a clinical-stage biotechnology company focused on the development of advanced T-cell immunotherapies, has…
Genentech’s Tecentriq Moves Closer to Potential New Standard of Care in Early Colon Cancer Following FDA Priority Review Acceptance Genentech, a member of the Roche Group, has announced that the…
Galderma Global Survey Reveals Rising Demand for Long-Lasting, Natural-Looking Anti-Wrinkle Treatments Galderma has unveiled the results of a major international survey examining the expectations, preferences, and experiences of both patients…
GENESIS Pharma and Alnylam Expand Strategic Partnership to Bring RNAi Therapies to Nordic Markets GENESIS Pharma has announced a significant expansion of its long-standing collaboration with Alnylam Pharmaceuticals, further strengthening…
Roquette to Showcase Advanced Drug Delivery and Pharmaceutical Solutions at CPHI & PMEC China 2026 Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, has announced its participation in…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June…
Poxel Appoints Yves Decadt as Chief Executive Officer to Lead Next Phase of Growth and Strategic Development French biopharmaceutical company Poxel has announced the appointment of Yves Decadt as its…
KARL STORZ Receives FDA Clearance for Rubina™ Lens Exoscope, Expanding Near-Infrared Imaging Capabilities in Open Surgery KARL STORZ, a global leader in endoscopic and minimally invasive surgical technologies, has announced…